# Martin Erik Nyeland

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/martin-erik-nyeland/

## Facts

| Field | Value |
| --- | --- |
| Citations | 383 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Steno Diabetes Centers |
| OpenAlex ID | https://openalex.org/A5073490328 |
| ORCID iD | 0000-0002-6044-7520 |
| Works | 22 |

## Researcher papers

- [Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients](https://scholariq.org/papers/developing-and-validating-covid-19-adverse-outcome-risk-prediction-models-from-a-2/)
- [Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.](https://scholariq.org/papers/increasing-severity-of-atopic-dermatitis-is-associated-with-a-negative-impact-on/)
- [Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial](https://scholariq.org/papers/effects-of-3-months-of-10-h-per-day-time-restricted-eating-and-3-months-of/)
- [Higher self‐reported severity of atopic dermatitis in adults is associated with poorer self‐reported health‐related quality of life in France, Germany, the U.K. and the U.S.A.](https://scholariq.org/papers/higher-self-reported-severity-of-atopic-dermatitis-in-adults-is-associated-with/)
- [Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data](https://scholariq.org/papers/evaluating-the-effectiveness-of-risk-minimisation-measures-the-application-of-a/)
- [The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study](https://scholariq.org/papers/the-adaptive-covid-19-treatment-trial-1-actt-1-in-a-real-world-population-a/)
- [Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in <scp>UK</scp> primary care](https://scholariq.org/papers/evaluation-of-the-effectiveness-of-liraglutide-and-sitagliptin-in-type-2/)
- [Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison](https://scholariq.org/papers/calcipotriol-plus-betamethasone-dipropionate-aerosol-foam-vs-apremilast/)
- [Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries](https://scholariq.org/papers/cost-per-pasi-75-responder-of-calcipotriol-plus-betamethasone-dipropionate/)
- [DEVELOPING AND VALIDATING COVID-19 ADVERSE OUTCOME RISK PREDICTION MODELS FROM A BI-NATIONAL EUROPEAN COHORT OF 5594 PATIENTS](https://scholariq.org/papers/developing-and-validating-covid-19-adverse-outcome-risk-prediction-models-from-a/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Researcher university

- [Steno Diabetes Centers](https://scholariq.org/institutions/steno-diabetes-centers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.